Almost 90 percent of Takeda shareholders voted to approve the deal at an extraordinary general meeting held in Osaka, western Japan, the company said. Takeda will be joining the ranks of the world’s top 10 drugmakers and gaining expertise in rare diseases through the deal, the biggest overseas acquisition by a Japanese company.
Original published: 2018-12-05 06:09:14 Read the full Osaka News here
Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.